A citation-based method for searching scientific literature

Yves Pommier, Mark J O'Connor, Johann de Bono. Sci Transl Med 2016
Times Cited: 283



Sylvie M Noordermeer, Haico van Attikum. Trends Cell Biol 2019
Times Cited: 103




List of shared articles



Times cited

BRCA1 and BRCA2 associated breast cancer and the roles of current modelling systems in drug discovery.
Oliver Trusler, Jacob Goodwin, Andrew L Laslett. Biochim Biophys Acta Rev Cancer 2021
0

Zebrafish as an in vivo screening tool to establish PARP inhibitor efficacy.
Jeroen Vierstraete, Charlotte Fieuws, Andy Willaert, Anne Vral, Kathleen Bertha Michaël Claes. DNA Repair (Amst) 2021
0

Alternate therapeutic pathways for PARP inhibitors and potential mechanisms of resistance.
Dae-Seok Kim, Cristel V Camacho, W Lee Kraus. Exp Mol Med 2021
8

Overcoming PARPi resistance: Preclinical and clinical evidence in ovarian cancer.
M Chiappa, F Guffanti, F Bertoni, I Colombo, G Damia. Drug Resist Updat 2021
3


Exploiting synthetic lethality to target BRCA1/2-deficient tumors: where we stand.
Parasvi S Patel, Arash Algouneh, Razq Hakem. Oncogene 2021
6

CRISPR Screens in Synthetic Lethality and Combinatorial Therapies for Cancer.
Laia Castells-Roca, Eudald Tejero, Benjamín Rodríguez-Santiago, Jordi Surrallés. Cancers (Basel) 2021
2

Targeting the nucleotide salvage factor DNPH1 sensitizes BRCA-deficient cells to PARP inhibitors.
Kasper Fugger, Ilirjana Bajrami, Mariana Silva Dos Santos, Sarah Jane Young, Simone Kunzelmann, Geoff Kelly, Graeme Hewitt, Harshil Patel, Robert Goldstone, Thomas Carell,[...]. Science 2021
7


Genome-wide CRISPR screens reveal cyclin C as synthetic survival target of BRCA2.
Mengfan Tang, Guangsheng Pei, Dan Su, Chao Wang, Xu Feng, Mrinal Srivastava, Zhen Chen, Zhongming Zhao, Junjie Chen. Nucleic Acids Res 2021
0

Exploiting DNA repair pathways for tumor sensitization, mitigation of resistance, and normal tissue protection in radiotherapy.
Jac A Nickoloff, Lynn Taylor, Neelam Sharma, Takamitsu A Kato. Cancer Drug Resist 2021
2

Tackling PARP inhibitor resistance.
Kasper Fugger, Graeme Hewitt, Stephen C West, Simon J Boulton. Trends Cancer 2021
0